Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen Revenue 2006-2019 | BIIB

Biogen annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Biogen revenue for the quarter ending September 30, 2019 was $3.600B, a 4.68% increase year-over-year.
  • Biogen revenue for the twelve months ending September 30, 2019 was $14.233B, a 7.55% increase year-over-year.
  • Biogen annual revenue for 2018 was $13.453B, a 9.61% increase from 2017.
  • Biogen annual revenue for 2017 was $12.274B, a 7.21% increase from 2016.
  • Biogen annual revenue for 2016 was $11.449B, a 6.36% increase from 2015.
  
Biogen Annual Revenue
(Millions of US $)
2018 $13,453
2017 $12,274
2016 $11,449
2015 $10,764
2014 $9,703
2013 $6,932
2012 $5,516
2011 $5,049
2010 $4,716
2009 $4,377
2008 $4,098
2007 $3,172
2006 $2,683
2005 $2,423
Biogen Quarterly Revenue
(Millions of US $)
Q3 2019 $3,600
Q2 2019 $3,617
Q1 2019 $3,490
Q4 2018 $3,526
Q3 2018 $3,439
Q2 2018 $3,357
Q1 2018 $3,131
Q4 2017 $3,307
Q3 2017 $3,078
Q2 2017 $3,078
Q1 2017 $2,811
Q4 2016 $2,872
Q3 2016 $2,956
Q2 2016 $2,894
Q1 2016 $2,727
Q4 2015 $2,839
Q3 2015 $2,778
Q2 2015 $2,592
Q1 2015 $2,555
Q4 2014 $2,641
Q3 2014 $2,511
Q2 2014 $2,421
Q1 2014 $2,130
Q4 2013 $1,966
Q3 2013 $1,828
Q2 2013 $1,723
Q1 2013 $1,415
Q4 2012 $1,418
Q3 2012 $1,386
Q2 2012 $1,421
Q1 2012 $1,292
Q4 2011 $1,327
Q3 2011 $1,310
Q2 2011 $1,209
Q1 2011 $1,203
Q4 2010 $1,219
Q3 2010 $1,176
Q2 2010 $1,213
Q1 2010 $1,109
Q4 2009 $1,127
Q3 2009 $1,121
Q2 2009 $1,093
Q1 2009 $1,036
Q4 2008 $1,069
Q3 2008 $1,093
Q2 2008 $993
Q1 2008 $942
Q4 2007 $893
Q3 2007 $789
Q2 2007 $773
Q1 2007 $716
Q4 2006 $708
Q3 2006 $703
Q2 2006 $660
Q1 2006 $611
Q4 2005 $633
Q3 2005 $596
Q2 2005 $606
Q1 2005 $588
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $50.996B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.118B 15.10
CSL (CSLLY) Australia $83.969B 0.00
Gilead Sciences (GILD) United States $81.336B 10.08
Celgene (CELG) United States $77.805B 11.11
Vertex Pharmaceuticals (VRTX) United States $54.001B 55.12
Illumina (ILMN) United States $45.080B 49.46
Regeneron Pharmaceuticals (REGN) United States $37.351B 16.35
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.893B 11.80
Seattle Genetics (SGEN) United States $19.834B 0.00
Incyte (INCY) United States $18.845B 43.74
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
Genmab (GNMSF) Denmark $14.056B 62.08
BioMarin Pharmaceutical (BMRN) United States $13.502B 0.00
Exact Sciences (EXAS) United States $10.667B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.338B 0.00
Galapagos (GLPG) Belgium $10.332B 26.62
BeiGene (BGNE) Cayman Islands $9.307B 0.00
QIAGEN (QGEN) Netherlands $9.257B 30.18
Amarin (AMRN) Ireland $8.073B 0.00
Bio-Techne Corp (TECH) United States $8.058B 53.93
Guardant Health (GH) United States $7.399B 0.00
Sarepta Therapeutics (SRPT) United States $7.298B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.942B 0.00
Moderna (MRNA) United States $6.482B 0.00
Reata Pharmaceuticals (RETA) United States $6.275B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.755B 14.63
ARGENX SE-ADR (ARGX) Netherlands $5.392B 0.00
Exelixis (EXEL) United States $4.931B 13.87
Medicines (MDCO) United States $4.676B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
Ascendis Pharma (ASND) Denmark $4.508B 0.00
Repligen (RGEN) United States $4.499B 81.54
Spark Therapeutics (ONCE) United States $4.282B 0.00
Bluebird Bio (BLUE) United States $4.150B 0.00
Adaptive Biotechnologies (ADPT) United States $3.748B 0.00
Blueprint Medicines (BPMC) United States $3.668B 0.00
Mirati Therapeutics (MRTX) United States $3.653B 0.00
MorphoSys AG (MOR) Germany $3.563B 0.00
Immunomedics (IMMU) United States $3.442B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.231B 0.00
Alkermes (ALKS) Ireland $3.176B 0.00
Genmab (GMAB) Denmark $2.923B 6.02
Emergent Biosolutions (EBS) United States $2.806B 27.87
Halozyme Therapeutics (HALO) United States $2.767B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.717B 0.00
NeoGenomics (NEO) United States $2.532B 134.72
MyoKardia (MYOK) United States $2.497B 0.00
Amicus Therapeutics (FOLD) United States $2.441B 0.00
UniQure (QURE) Netherlands $2.314B 0.00
Arena Pharmaceuticals (ARNA) United States $2.266B 5.27
Acceleron Pharma (XLRN) United States $2.255B 0.00
Zai Lab (ZLAB) China $2.251B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.121B 0.00
Cambrex (CBM) United States $2.017B 25.46
Myriad Genetics (MYGN) United States $1.841B 27.20
Ligand Pharmaceuticals (LGND) United States $1.818B 34.97
Insmed (INSM) United States $1.797B 0.00
Akcea Therapeutics (AKCA) United States $1.762B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.514B 0.00
Zymeworks (ZYME) Canada $1.465B 0.00
Denali Therapeutics (DNLI) United States $1.464B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.464B 0.00
Epizyme (EPZM) United States $1.404B 0.00
REGENXBIO (RGNX) United States $1.377B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.350B 0.00
Coherus BioSciences (CHRS) United States $1.345B 0.00
Innoviva (INVA) United States $1.267B 3.73
Editas Medicine (EDIT) United States $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Zealand Pharma (ZEAL) Denmark $1.161B 0.00
Alector (ALEC) United States $1.094B 0.00
Sangamo Therapeutics (SGMO) United States $1.083B 0.00
Fate Therapeutics (FATE) United States $1.081B 0.00
Arvinas (ARVN) United States $1.048B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.997B 0.00
WAVE Life Sciences (WVE) Singapore $0.980B 0.00
Principia Biopharma (PRNB) United States $0.954B 0.00
Athenex (ATNX) United States $0.887B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Codexis (CDXS) United States $0.865B 0.00
Anika Therapeutics (ANIK) United States $0.857B 27.82
Cara Therapeutics (CARA) United States $0.847B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.830B 6.98
Vericel (VCEL) United States $0.824B 307.17
ZIOPHARM Oncology Inc (ZIOP) United States $0.816B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.721B 184.16
Revance Therapeutics (RVNC) United States $0.719B 0.00
Twist Bioscience (TWST) United States $0.691B 0.00
ANI Pharmaceuticals (ANIP) United States $0.678B 11.56
DBV Technologies S.A (DBVT) France $0.671B 0.00
Intellia Therapeutics (NTLA) United States $0.665B 0.00
MiMedx (MDXG) United States $0.653B 0.00
Precision BioSciences (DTIL) United States $0.643B 0.00
Agenus (AGEN) United States $0.604B 0.00
Mesoblast (MESO) Australia $0.601B 0.00
Adverum Biotechnologies (ADVM) United States $0.590B 0.00
GENFIT S.A (GNFT) France $0.580B 0.00
Cellectis S.A (CLLS) France $0.565B 0.00
Retrophin (RTRX) United States $0.559B 0.00
BioDelivery Sciences (BDSI) United States $0.545B 0.00
UROGEN PHARMA (URGN) United States $0.545B 0.00
Kadmon Holdings (KDMN) United States $0.536B 0.00
Stemline Therapeutics (STML) United States $0.525B 0.00
Cytokineticsorporated (CYTK) United States $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.493B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.479B 0.00
Intra-Cellular Therapies (ITCI) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.476B 11.02
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.409B 0.00
Clovis Oncology (CLVS) United States $0.387B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.375B 2.60
Merus (MRUS) Netherlands $0.366B 0.00
Bellus Health (BLU) Canada $0.364B 0.00
Cellular Biomedicine (CBMG) United States $0.349B 0.00
PDL BioPharma (PDLI) United States $0.344B 8.60
Arcus Biosciences (RCUS) United States $0.336B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.326B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.305B 0.00
AnaptysBio (ANAB) United States $0.301B 0.00
Compugen (CGEN) Israel $0.293B 0.00
Avid Bioservices (CDMO) United States $0.291B 0.00
Kindred Biosciences (KIN) United States $0.288B 0.00
Protagonist Therapeutics (PTGX) United States $0.278B 0.00
Pfenex (PFNX) United States $0.270B 0.00
Sutro Biopharma (STRO) United States $0.263B 0.00
Cel-Sci (CVM) United States $0.261B 0.00
Gritstone Oncology (GRTS) United States $0.261B 0.00
Seres Therapeutics (MCRB) United States $0.256B 0.00
Geron (GERN) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.07
MannKind (MNKD) United States $0.248B 0.00
Theratechnologies (THTX) Canada $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
Kamada (KMDA) Israel $0.239B 6.98
OSMOTICA PHARM (OSMT) United States $0.238B 0.00
CytomX Therapeutics (CTMX) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.232B 0.00
Inovio Pharmaceuticals (INO) United States $0.228B 0.00
XOMA (XOMA) United States $0.226B 0.00
Albireo Pharma (ALBO) United States $0.225B 0.00
Athersys (ATHX) United States $0.218B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
Scholar Rock Holding (SRRK) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Cue Biopharma (CUE) United States $0.209B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Sorrento Therapeutics (SRNE) United States $0.194B 0.00
Exicure (XCUR) United States $0.187B 0.00
Affimed (AFMD) Germany $0.185B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.184B 0.00
Spero Therapeutics (SPRO) United States $0.181B 0.00
Palatin Technologies (PTN) United States $0.180B 4.91
CorMedix Inc (CRMD) United States $0.173B 0.00
Dyadic (DYAI) United States $0.171B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.168B 0.00
Arsanis (XFOR) United States $0.165B 0.00
Senesco Technologies (ELOX) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Alcobra (ARCT) United States $0.147B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Cerecor (CERC) United States $0.137B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Fortress Biotech (FBIO) United States $0.133B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.131B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
BioTime (LCTX) United States $0.130B 6.65
Ophthotech (ISEE) United States $0.125B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Five Prime Therapeutics (FPRX) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
NantKwest (NK) United States $0.112B 0.00
Aptinyx (APTX) United States $0.106B 0.00
OvaScience (MLND) United States $0.106B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
VBI Vaccines (VBIV) United States $0.106B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Novavax (NVAX) United States $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
Celyad SA (CYAD) Belgium $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Aduro Biotech (ADRO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.080B 0.00
Strongbridge Biopharma (SBBP) United States $0.080B 2.13
Acorda Therapeutics (ACOR) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Selecta Biosciences (SELB) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Verastem (VSTM) United States $0.064B 0.00
Synlogic (SYBX) United States $0.063B 0.00
Trevena (TRVN) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Checkpoint Therapeutics (CKPT) United States $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Orgenesis (ORGS) United States $0.053B 3.39
China Health Industries Holdings (CHHE) China $0.052B 15.78
Applied Genetic Technologies (AGTC) United States $0.051B 0.00
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Curis (CRIS) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Celsion (CLSN) United States $0.032B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.56
VIVUS (VVUS) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
VistaGen Therapeutics (VTGN) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Advaxis (ADXS) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.003B 0.00
Neuralstem (SNCA) United States $0.002B 0.00